15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Alterity Therapeutics Ltd, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $10.00 to $16.00, a moderate spread. The average target of $13.00 sits 179% above the current $4.67. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 3 over recent months. On the fundamentals, the Street sees revenue growth near -35% this year and -68% next.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Alterity Therapeutics Ltd.
As of Jul, 3 of 3 firms rate ATHE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering Alterity Therapeutics Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATHE.
#1
Jason McCarthy
Maxim Group · Rank #360
Buy
$12.00+157.2% to target
Overall win rate
30%
+ Follow
#2
DC
Debanjana Chatterjee
Jones Trading
Buy
$16.00+243.0% to target
Coverage
—
+ Follow
ATHE stock forecast FAQ
What is ATHE's average 12-month price target?+
The 2 analysts with a live target average $13.00 for Alterity Therapeutics Ltd over the next 12 months, ranging from a $16.00 high to a $10.00 low.
Is ATHE stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ATHE?+
The Street-high target is $16.00 (Jones Trading), and the Street-low is $10.00 (Ladenburg Thalmann). The average of all 2 active targets is $13.00.
How many Wall Street analysts cover ATHE?+
3 analysts have an active rating on Alterity Therapeutics Ltd, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering ATHE?+
Among analysts who currently cover ATHE, Jason McCarthy of Maxim Group has the strongest overall Quantellect track record (Rank #360). Their current call is Buy with a $12.00 target.
Have analysts been upgrading or downgrading ATHE lately?+
As of Jul, 3 of 3 firms rate ATHE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATHE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Ladenburg Thalmann
